多焦視網膜電流圖評估雷珠單抗玻璃體腔注射治療年齡相關性黃斑變性療效的價值
發(fā)布時間:2019-08-06 13:03
【摘要】:目的應用多焦視網膜電流圖(mfERG)評價雷珠單抗治療年齡相關性黃斑變性(AMD)療效的價值。方法 AMD患者31例(31眼)接受玻璃體腔注射雷珠單抗治療,每月1次,共3次。比較治療前后患眼mfERG檢測中1-5環(huán)反應振幅、潛伏期及最佳矯正視力的變化。結果治療后,患眼mfERG反應振幅1、2環(huán)高于治療前(P0.01),反應潛伏期1-5環(huán)均有降低(P0.05或P0.01)。結論 mfERG能明確顯示雷珠單抗治療AMD能有效改善視網膜的生理功能。
[Abstract]:Objective to evaluate the efficacy of razumab in the treatment of age-related macular degeneration (AMD) by multifocal electroretinal electrography (mfERG). Methods 31 patients (31 eyes) with AMD were treated with vitreous injection of rapezumab once a month for 3 times. The changes of amplitude, latency and best corrected visual acuity of 1 鈮,
本文編號:2523563
[Abstract]:Objective to evaluate the efficacy of razumab in the treatment of age-related macular degeneration (AMD) by multifocal electroretinal electrography (mfERG). Methods 31 patients (31 eyes) with AMD were treated with vitreous injection of rapezumab once a month for 3 times. The changes of amplitude, latency and best corrected visual acuity of 1 鈮,
本文編號:2523563
本文鏈接:http://www.sikaile.net/yixuelunwen/yank/2523563.html
最近更新
教材專著